Haag and Larson (1) demonstrated in 1942 that in the case of nicotine the extent of urinary excretion of a chemical may be related to the reaction of urine. They emphasized the importance of taking into consideration the dissociation constant of a drug and the relative reabsorbability of the free and dissociated base. Extending these studies to the urinary excretion of quinine in man, Haag, Larson and Schwartz (2) found in 1943 that the urinary output could be doubled by passing from an alkaline to an acid urine and they ascribed the difference to greater resorption of quinine from the urinary tract when the urine is alkaline.
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In connection with studying the behavior of newer antimalarial drugs in man, the extent of the influence of urinary acid-base balance upon renal excretion was re-examined. Parallel studies by Emerson and Dole (3) indicated that renal clearance of quinacrine is subject to 100-fold variations due principally to 2 variables, the urinary pH and the renal plasma flow. Work conducted at the same time by the Army Malaria Research Unit at Oxford (4) emphasized the striking parallelism between urinary excretion of quinacrine and ammonia. They found that the ratio of urinary quinacrine to urinary ammonia is directly proportional to the plasma quinacrine concentration. Trager and Hutchinson (5) in 1946 similarly found the urinary excretion of quinacrine to be closely correlated with the urinary excretion of ammonia.
The present investigation was designed to ascertain the effect of oral ingestion of alkali and acid upon the renal excretion of this general type of organic compound. The substances selected for study were quinacrine, chloroquine (SN-7618), and santoquine (SN-6911).
METHODS AND MATERIALS
The patients utilized in this study were from the middle and older age groups. No restriction was placed on the diet or upon water intake during the observations and the patients were permitted the freedom of the ward. All drugs were administered orally and according to a single general dosage pattern. A high initial dose was administered during the first 24 hours and this was followed by the serial administration of smaller maintenance doses. Several days were allowed to elapse for the stabilization of the plasma drug concentration before observations were begun.
Alkali was administered orally in the form of sodium bicarbonate at a total daily dose of 20 grams. This was given in doses of 2.5 grams at 2-hour intervals during the day for 7 doses and once during the night. Acid was administered orally in the form of ammonium chloride at a total daily dose of 8 grams. The dosage schedule was the same as for the bicarbonate, each dose being 1.0 gram.
Plasma and urine estimations were performed by methods developed by Brodie. Quinacrine was determined fluorometrically by the single extraction procedure using ethylene dichloride (6); the alkaline wash was used in the urine determinations but not in the plasma determinations. The ethylene dichloride extract was made acid with trichloracetic acid (Masen [7] ). Santoquine was estimated by the colorimetric procedure depending upon a salt formation with methyl orange (Brodie et al [8] ).
The recently developed specific method (1947) for the analysis of chloroquine (9) , involving the use of heptane and alkaline washes, was not yet available at the time of the present study. The procedure used involved the extraction of chloroquine with ethylene dichloride at pH 11, followed by the return of the drug to dilute acid. The acid solution was buffered at pH 9.5 and subjected to ultra-violet irradiation for a 1-hour period. Concentration was estimated by measurement of fluorescence generated by the irradiation. This procedure includes in the measurement interfering degradation products of chloroquine which are found in plasma to the extent of 20 to 50 per cent. However, it is quite specific for urine since only negligible amounts of these degradation products appear in urine.
Urine pH was determined in all cases on freshly voided urine samples using a glass electrode. No precautions were taken to maintain CO2 tensions in the transfer of fluid. Consequently the data on urinary pH must be taken as close approximations rather than precise estimations of the pH of bladder urine. During the period of alkali administration the urinary pH rose to values between 7.5 and 8.0; during the acid period the pH fell to values of 4.0 to 5.0.
RESULTS

Quinacrine
The experimental data obtained on 4 patients receiving maintenance doses of 0.2 and 0.3 grams of quinacrine dihydrochloride are summarized in Table I per cent in the control periods; was reduced to 7 to 20 per cent during alkalinization and was increased to 20 to 90 per cent during acidification.
Santoquine
Observations on santoquine were limited to a single individual. However, they were designed to stress the effects of changes in the renal excretion of drug upon the maintenance of the plasma santoquine concentration while on a constant drug intake. Each phase of alkali and acid administration was of 5 days' duration and 2 complete cycles of alkali-acid treatment were obtained (Table III) . As is to be expected in such a circumstance, the plasma santoquine concentrations reveal a cycle which can be correlated with the intervals of low and high renal excretion. During the alkaline phase of low drug excretion, the plasma level slowly rose; during the acid phase of high excretion, the plasma level fell.
DISCUSSION
It is apparent from the data that the renal excretion of the anti-malarial drugs is dependent upon a series of variables in addition to the concurrent plasma concentration. These variables are of sufficient importance in the determination of the renal drug excretion, that the latter may not be used directly as an approximation method to estimate the general level of the plasma drug concentration.
The refinement introduced by the British workers (4) involving the simultaneous measurement of urinary ammonia and quinacrine does permit of an indirect determination of plasma quinacrine from measurements on urine alone. It appears to us that ammonia excretion may be governed by urinary acid-base balance in a manner similar to the other weak organic bases, such as the anti-malarial drugs. The ammonia measurement provides an index of variation in urinary acid-base balance. By taking the quinacrine concentrations in relationship to ammonia excretion, the Oxford workers were able to eliminate the variable of pH. Trager and Hutchinson (5) seem to ascribe a causal role to ammonia in promotion of urinary excretion; it appears far more likely that ammonia and quinacrine excretions are concomitantly altered in a similar manner by urinary changes in hydrogen ion concentration.
The experimental data are interesting for yet another reason. It must be assumed that at least a portion of the drug eliminated by the kidneys is excreted by a process other than glomerular filtration. This follows from a consideration (in the case of quinacrine) of the extent to which it is bound to the non-diffusible constituents of plasma (some 80 to 90 per cent of the total) and the observed rates of excretion. The mechanism responsible for such tubular excretion as occurs ap-pears to be quite different from those responsible for the tubular excretion of such substances as phenol red, creatinine, diodrast, etc. The latter manifest considerable stability whereas this does not obtain for the tubular excretion either of quinacrine or of chloroquine and santoquine.
Data are not available with which to define the mechanisms involved though there is sufficient to warrant certain reasonable speculations. It is suggested that a small portion of the excreted anti-malarial drug is filtered at the glomerulus, the amount determined by the glomerular filtration rate, and the concentration of unbound drug in plasma water. A second portion is considered to be added to this in the proximal segment by a process of active tubular excretion similar to the conventional processes considered above. The combined filtered and secreted drug is presented to the distal segment of the nephron in concentrated form due in part to the reabsorption of water in the proximal tubule and loop of Henle. In the distal segment, a process of adjustment of hydrogen ion concentration takes place followed by equilibration of drug across the tubular membrane. The data are in keeping with the assumption that free base is more freely diffusible across the cells of the distal segment than the monoacidic and diacidic salts of the drugs studied. Such being the case there may be expected to be net gain or loss of drug depending upon the relation between the hydrogen ion concentration of the tubular urine and that of peritubular fluid (ca. 7. 34). Alkalinization of the tubular urine would increase the proportion of drug in the form of free base and in this way would promote reabsorption; acidification would counteract reabsorption by reducing the proportion of free base. A somewhat similar mechanism has been suggested to cover the renal tubular excretion of neutral red in the amphibian kidney (10) .
The observation of Trager and Hutchinson (5) that the plasma quinacrinie level rose soon after oral ingestion of large doses of ammonium chloride, would seem to provide another basis for the altered urinary excretion. The elevation in plasma level observed in their experiment is of brief duration and is in keeping with the increased plasma levels observed in dog experiments (11 ) 
